Frontlight ResearchEarly access
Trial site
Affiliated Eye Hospital of Nanchang University
- 3running trials
- 1closed trial
The trials here
What the 5 trials at this site are about, from their registry records.
- Conditions
- Macular degeneration3 trials
- Glaucoma1 trial
- Phase
- Phase 33 trials
- Phase 41 trial
- Status
- Active, not recruiting1 trial
- Completed1 trial
- Not yet recruiting1 trial
- Recruiting1 trial
- Suspended1 trial
- Lead sponsor
- BioDlink Biopharm Co., Ltd.1 trial
- Oupushifang Pharmaceutical Technology Co., Ltd.1 trial
- Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine1 trial
- Shanghai Henlius Biotech1 trial
- Sun Yat-sen University1 trial
Running trials
Not yet recruiting
Recruiting
Active, not recruiting
TAB014 Compared to Lucentis® in Patients with Neovascular Age-related Macular Degeneration
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Macular degeneration1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 17 Nov 2026